Plasma, often referred to as the fourth state of matter, is an ionized or energized gas with an equal number of positive and negative charges. The gas plasma is widely used for inactivation of a wide range of microorganisms present on surgical/medical instruments. Plasma sterilizers are medical devices employed for decontamination of surgical/medical instruments used during surgical and other medical procedures. Different types of gases such as oxygen, nitrogen, hydrogen peroxide, helium, and neon are used as a source of plasma. Different plasma production methods are applied for elimination or inactivation of microorganisms. Plasma sterilization can be performed either at a low temperature or at a high temperature, depending on the requirement. Plasma sterilization facilitates the sterility assurance level (SAL) of 10–6 and this method offers high material and functional capability. Plasma sterilization provides several advantages over traditional sterilization methods, as it is a safe, non-toxic, time-saving, more rapid, energy efficient, non-thermal method. It does not leave any chemical residues on instruments. Thus, it serves as an alternative for traditional sterilization methods such as autoclaving, gamma ray, electron beam, dry heating, and chemical method.
The demand for plasma sterilizers is anticipated to be greatly influenced by their value-added advantages and limitations of conventional sterilization methods. The gas plasma sterilization using hydrogen peroxide facilitates sterilization at a lower temperature, which is likely to boost the demand for hydrogen peroxide plasma sterilizers for thermo-sensitive materials during the forecast period. Also, increasing use of low-temperature gas plasma sterilizers in hospitals and ambulatory surgical centers and rising demand for alternative sterilization techniques for temperature-sensitive materials are factors anticipated to drive the plasma sterilizers market in the next few years. Moreover, increase in the number of hospitals and ambulatory surgical centers in developing countries is projected to augment the plasma sterilizers market in the near future. However, inability to process liquids, powders, strong absorbers; inability to penetrate deeply into long-lumen medical devices; and small chamber size are some of the limitations of plasma sterilizers. These limitations are likely to hamper the demand for gas plasma sterilizers during the forecast period.
The global plasma sterilizers market can be broadly segmented based on temperature, source gas, and geography. Based on temperature, the market has been further segmented into low-temperature plasma sterilizers and high-temperature plasma sterilizers. Low-temperature plasma sterilizers are used in surface modification, sterilization, and decontamination applications. Low-temperature plasmas are produced under deep-vacuum (low-pressure) conditions. The low-temperature plasma sterilizers segment is projected to account for a leading market share by 2025. Based on source of gas, the plasma sterilizers market has been segmented into oxygen gas, nitrogen gas, hydrogen peroxide gas, and other inert gases. The hydrogen peroxide gas is most commonly used for sterilization of temperature-sensitive equipment. The hydrogen peroxide gas segment is projected to dominate the market between 2017 and 2025. Low-temperature plasma sterilizers that utilize hydrogen peroxide are compatible with more than 95% of medical devices and materials.
Based on geography, the global plasma sterilizers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are anticipated to dominate the global plasma sterilizers market during the forecast period, owing to well-established health care infrastructure and early adoption of new sterilization technologies in these regions. The market in Asia Pacific is projected to expand at the maximum growth rate during the forecast period, primarily due to rapid expansion of health care infrastructure in countries such as India, China, South Korea, and Malaysia; increase in the number of multinational hospital chains; and rise in the demand for low-temperature plasma sterilizers for temperature-sensitive medical devices and instruments in the region. The market in Latin America and Middle East & Africa is likely to expand at a moderate growth rate during the forecast period.
Key players operating in the global plasma sterilizers market are STERIS plc, SciCan Ltd., RENOSEM Co. Ltd., Johnson & Johnson, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., BIOBASE Group, CISA production srl, Tuttnauer, H.W. Andersen Products Ltd., and Stericool.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.